Summary
With aging, multiple physiological changes occur in the connective tissue and vasculature of the nose which may predispose or contribute to chronic rhinitis. Accurate differentiation of allergic from nonallergic causes of rhinitis requires skin testing or in vitro measures of specific IgE.
Empiric treatment with over-the-counter first generation antihistamines and oral decongestants frequently results in CNS, anticholinergic and cardiovascular adverse effects. While newer second generation histamine antagonists do not cause these problems, selected drugs in this class may cause electrocardiographic QT prolongation and, in rare cases, ventricular arrhythmias. Topical therapies including sodium cromoglycate (cromolyn sodium), corticosteroids and ipratropium bromide are all well-tolerated with minimal adverse effects.
Avoidance of allergens and/or irritants is an important adjunct in treating patients with allergic and vasomotor rhinitis. If all other therapies fail in patients with confirmed allergic rhinitis, immunotherapy can be safely instituted in most older patients.
Similar content being viewed by others
References
Patterson CN. The aging nose: characteristics and correction. Otolarngol Clin North Am 1980; 13: 275–88
Hollander AR. Histopathology of the nasal mucosa of older persons. Arch Otorhinol 1944; 40: 92–100
Bende M. Blood flow with 132Xe in human nasal mucosa in relation to age, sex and body position. Acta Otorhinol 1983; 96: 175–9
Broder I, Higgins MW, Matthews KP, et al. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. J Allergy Clin Immunol 1974; 53: 127–38
Drake-Lee AB, Lowe D, Swanston DL, et al. Clinical profile and recurrence of nasal polyps. J Laryngol Otol 1984; 98: 783–93
Moore GF, Freeman TJ, Ogren FP, et al. Extended follow-up of total inferior turbinate resection for relief of chronic nasal obstruction. Laryngoscope 1985; 95: 1095–9
Meltzer EO. Comparative safety of H1 antihistamines. Ann Allergy 1991; 67: 625–33
Simons KJ, Watson WTA, Chen WY, et al. Pharmacokinetic and pharmacodynamic studies of the H1-receptor antagonist hydroxyzine in the elderly. Clin Pharmacol Ther 1989; 45: 9–14
Simons KJ, Martin TJ, Watson WTA, et al. Pharmacokinetics and pharmacodynamics of terfenadine and chlorpheniramine in the elderly. J Allergy Clin Immunol 1990; 85: 540–7
Simons KJ, Watson WTA, Martin TJ, et al. Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults and children. J Clin Pharmacol 1990; 30: 665–71
Woosley RL, Chen YY, Freiman JP, et al. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993; 269: 1532–6
Craft TM. Torsade de Pointes after astemizole overdose. BMJ 1986; 292: 660–1
Hilbert J, Moritzen V, Parks A, et al. The pharmacokinetics of loratadine in normal geriatric volunteers. J Int Med Res 1988; 16: 59–61
Matzke GR, Yeh J, Awni WM, et al. Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiency. Ann Allergy 1987; 59 (Pt 2): 25–30
Lake CR, Gallant S, Masson E, et al. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. Am J Med 1990; 89: 195–208
Beck RA, Mercado DL, Seguin SM, et al. Cardiovascular effects of pseudoephedrine in medically controlled hypertensive patients. Arch Intern Med 1992; 152: 1242–5
Kroenke K, Omori DM, Simmons JO, et al. The safety of phenylpropanolamine in patients with stable hypertension. Ann Intern Med 1989; 111: 1043–4
Juniper EF, Guyatt GH, Archer B, et al. Aqueous beclometha sone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of ‘as needed’ use. J Allergy Clin Immunol 1993; 92 (1 Pt 1): 66–72
Milford CA, Mugliston TA, Lund VJ, et al. Long term safety and efficacy study of ipatropium bromide. J Laryngol Otol 1990; 104: 123–5
Mosbech H, Osterballe O. Does the effect of immunotherapy last after termination of treatment? Allergy 1988; 43: 523–9
Matloff SM, Bailit IW, Parks P, et al. Systemic reactions to immunotherapy. Allergy Proc 1993; 14: 347–450
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tan, R., Corren, J. Optimum Treatment of Rhinitis in the Elderly. Drugs & Aging 7, 168–175 (1995). https://doi.org/10.2165/00002512-199507030-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199507030-00002